Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver

PHASE3TerminatedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
AscitesLiver Cirrhosis
Interventions
DRUG

Satavaptan

oral administration once daily

DRUG

placebo

oral administration once daily

Trial Locations (21)

19355

Sanofi-Aventis Administrative Office, Malvern

Unknown

Sanofi-Aventis Administrative Office, San Isidro

Sanofi-Aventis Administrative Office, Macquarie Park

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, Sarajevo

Sanofi-Aventis Administrative Office, São Paulo

Sanofi-Aventis Administrative Office, Sofia

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Kuala Lumpur

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Warsaw

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Belgrade

Sanofi-Aventis Administrative Office, Singapore

Sanofi-Aventis Administrative Office, Barcelona

Sanofi-Aventis Administrative Office, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY